These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8176202)

  • 1. Donor T cells can be induced to grow and survive long term in vivo without previous host immunosuppression.
    Chen W; Cheever MA
    J Immunol; 1994 May; 152(10):4767-74. PubMed ID: 8176202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptively transferred antigen-specific T cells can be grown and maintained in large numbers in vivo for extended periods of time by intermittent restimulation with specific antigen plus IL-2.
    Chen W; Reese VA; Cheever MA
    J Immunol; 1990 May; 144(10):3659-66. PubMed ID: 2332628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells.
    Greenberg PD; Cheever MA
    J Immunol; 1984 Dec; 133(6):3401-7. PubMed ID: 6149246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.
    Klarnet JP; Matis LA; Kern DE; Mizuno MT; Peace DJ; Thompson JA; Greenberg PD; Cheever MA
    J Immunol; 1987 Jun; 138(11):4012-7. PubMed ID: 3108381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo.
    Chen W; Schweins E; Chen X; Finn OJ; Cheever MA
    J Immunol; 1994 Oct; 153(8):3630-8. PubMed ID: 7930583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 administered in vivo induces the growth and augments the function of cultured T cells in vivo.
    Cheever MA; Thompson JA; Kern DE; Greenberg PD
    J Biol Response Mod; 1984 Oct; 3(5):462-7. PubMed ID: 6334133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.
    Cheever MA; Greenberg PD; Irle C; Thompson JA; Urdal DL; Mochizuki DY; Henney CS; Gillis S
    J Immunol; 1984 May; 132(5):2259-65. PubMed ID: 6609193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
    Eberlein TJ; Rosenstein M; Spiess PJ; Rosenberg SA
    J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
    Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival of adoptively transferred tumor-infiltrating lymphocytes in mice.
    Alexander RB; Rosenberg SA
    J Immunol; 1990 Sep; 145(5):1615-20. PubMed ID: 1974569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
    Bristol JA; Schlom J; Abrams SI
    Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.
    Thompson JA; Peace DJ; Klarnet JP; Kern DE; Greenberg PD; Cheever MA
    J Immunol; 1986 Dec; 137(11):3675-80. PubMed ID: 3491145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cells for tumor therapy can be obtained from antigen-loaded sponge implants.
    Chen W; Reese VA; Cheever MA
    Cancer Res; 1994 Feb; 54(4):1065-70. PubMed ID: 8313363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioning.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2004 Nov; 32(11):1110-7. PubMed ID: 15539090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for specific cancer therapy with immune T lymphocytes.
    Cheever MA; Greenberg PD; Fefer A
    J Biol Response Mod; 1984; 3(2):113-27. PubMed ID: 6233396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of adoptive chemoimmunotherapy of established syngeneic tumors.
    Cheever MA; Greenberg PD; Fefer A
    J Immunol; 1980 Aug; 125(2):711-4. PubMed ID: 6156213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.
    Roychowdhury S; May KF; Tzou KS; Lin T; Bhatt D; Freud AG; Guimond M; Ferketich AK; Liu Y; Caligiuri MA
    Cancer Res; 2004 Nov; 64(21):8062-7. PubMed ID: 15520217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.